Chemical Structure (Atorvas Tab 01)
Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 82137-017
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 82137-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lepu Pharmaceutical Technology Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
02 (Atorvas Tab 02)
03 (Atorvas Tab 03)
This is a graph that compares the cumulative hazard (percentage) of the placebo group to that of the group receiving Atorvastatin for four years. The hazard ratio (HR) for Atorvastatin is 0.63, and the p-value is 0.001, indicating a significant reduction in the primary endpoint. The x-axis represents time to the first primary endpoint in years, and the y-axis represents the cumulative hazard percentage.*
04 (Atorvas Tab 04)
The text shows a comparison of subjects who experienced a major cardiovascular endpoint while taking Atorvastatin at two doses (10mg and 80mg). The results showed a significant difference between the two doses with the group taking Atorvastatin 80mg experiencing fewer cardiovascular events. The data is presented graphically over a 4-year period.*
Principal Display Panel (10 mg Tablet Bottle Label)
Atorvastatin Calcium Tablets, USP can be stored between 20-25°C (68-77°F) in tight containers. Each tablet contains 10 mg Atorvastatin Calcium, and the full prescribing information can be found in the package insert. They are manufactured by Lepu Pharmaceutical Technology Co., Ltd. in Taizhou City, China, and distributed by an unspecified company. The NDC is 82137-016-01, and the product is only available with a prescription. Revision is dated June 2022.*
Principal Display Panel (20 mg Tablet Bottle Label)
This is a label for Atorvastatin Calcium Tablets. The recommended storage temperature is between 20-25°C (68-77°F) and they should be dispensed in tight containers. For dosage and usage, the package insert should be consulted for full prescribing information. Each tablet contains Atorvastatin Calcium equivalent to 20mg Atorvastatin. The tablets are manufactured by Lepu Pharmaceutical Technology Co., Ltd in Taizhou City, Zhejiang Province, China. The NDC number is 82137-017-01, and the tablets are only available by prescription. The label was revised on June 2021.*
Principal Display Panel (40 mg Tablet Bottle Label)
This is a prescription drug package containing 90 tablets of Atorvastatin Calcium equivalent to 40 mg Atorvastatin per tablet. The drug details indicate that it should be stored in tight containers at a controlled room temperature of 20-25°C (68-77°F) and should be dispensed as per the USP guidelines. The package insert contains the necessary information regarding its dosage and usage. The drug is produced by Lepu Pharmaceutical Technology Co., Ltd in China and distributed under NDC82137-018-01.*
Principal Display Panel (80 mg Tablet Bottle Label)
This is a medication called Atorvastatin Calcium and it comes in tablets containing 80mg of Atorvastatin. It is recommended to be stored at room temperature between 20-25°C (68-77°F) and dispensed in tight containers. The packaging insert should be consulted for full prescribing information. The medicine is manufactured by Lepu Pharmaceutical Technology Co. Ltd. and distributed by an unknown company. The NDC number is also provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
